Home › Epilepsy › Michigan › Detroit
Epilepsy clinical trials in Detroit, MI
4 studies for Epilepsy are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
RecruitingPhase 3
- Wayne State University, Detroit
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
RecruitingPhase 3
- 9D University Health Center, Detroit
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- Wayne State University/Detroit Medical Center Comprehensive Epilepsy Program, Detroit
Functional Brain Mapping for Patients with Epilepsy
Recruiting
- Children's Hospital of Michigan, Detroit
- Wayne State University, Detroit
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA18 studies
- Houston, TX15 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Durham, NC9 studies
- Phoenix, AZ9 studies
- Rochester, MN9 studies
- Cleveland, OH9 studies
- Miami, FL8 studies
- Birmingham, AL7 studies
- Mountain View, CA6 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer34 studies
- Ovarian Cancer28 studies
- Cancer (all types)27 studies
- Colorectal Cancer25 studies
- Prostate Cancer23 studies
- Endometrial Cancer23 studies
- Metastatic Cancer22 studies
- Lung Cancer19 studies
- Multiple Myeloma19 studies
- Head and Neck Squamous Cell Carcinoma16 studies
- Stomach Cancer15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.